US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Corbus Pharmaceuticals Holdings, Inc. - Common Stock (NQ:CRBP)

5.850 -0.280 (-4.57%)
Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Corbus Pharmaceuticals Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Corbus CRB-913 Delivers 5% Weight Loss in Phase 1b Obesity Study ↗
Corbus Pharmaceuticals (NASDAQ:CRBP) reported top-line results from CANYON-1, a Phase 1b trial evaluating CRB-913, an oral, peripherally restricted CB1 inverse agonist for obesity. The 12-week,... 
Via MarketBeat
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
Cannabis Rally Turns Selective as Investors Reward Pharma-Tinged Names ↗
Via Chartmill
Topics Cannabis
News headline image
Corbus Pharmaceuticals Teases Cancer, Obesity Data as Key Clinical Readouts Near ↗
Corbus Pharmaceuticals (NASDAQ:CRBP) Chief Executive Yuval Cohen outlined the company’s near-term clinical readout schedule and development plans for its two lead drug candidates during a Jefferies... 
Via MarketBeat
Corbus Pharmaceuticals (NASDAQ:CRBP) Reports Narrower-Than-Expected Q4 Loss, Provides Pipeline Update ↗
Via Chartmill
CRBP Stock Surged 36% Pre-Market – What Did Its Obesity Treatment Drug Study Reveal? ↗
Via Stocktwits
News headline image
Corbus Pharmaceuticals Targets HPV-Linked Head and Neck Cancer With CRB-701 Study ↗
Corbus Pharmaceuticals (NASDAQ:CRBP) executives and oncology specialists used an ASCO-linked discussion to outline the rationale for focusing the company’s CRB-701 program on recurrent or metastatic... 
Via MarketBeat
Tuesday's session: top gainers and losers ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Gapping stocks in Tuesday's session ↗
Via Chartmill
News headline image
Corbus Pharmaceuticals Teases Key ASCO Cancer Data, Late-Summer Obesity Readout ↗
Corbus Pharmaceuticals (NASDAQ:CRBP) Chief Executive Officer Yuval Cohen said investors should expect more mature clinical updates for CRB-701 at the upcoming ASCO meeting, including the first... 
Via MarketBeat
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Discover the top movers in Friday's pre-market session. ↗
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Top movers in Thursday's after hours session ↗
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Corbus (CRBP) Q2 Loss Beats Estimates ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Cannabis Stock Gainers And Losers From July 16, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Movers For July 15, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Bullish Sentiment Across The Cannabis Space - Check Full Movers For July 9, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Marijuana Stock Movers For July 2, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Movers For June 30, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Movers For June 27, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Gainers And Losers From June 26, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Gainers And Losers From June 25, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Marijuana Stock Movers For June 23, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Marijuana Stock Movers For June 17, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Gainers And Losers From June 13, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Gainers And Losers From June 3, 2025 ↗
 
Via Benzinga
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >